Innovative Funding for Antibiotics and Progress Studies

Exploring the concept of offering bounties and advanced market commitments for the creation of new antibiotics, including the proposal by Nobel Prize winner Michael Kramer and the funding structure involving additional payments per dose sold. The chapter also highlights the difficulties in proving market demand for novel antibiotics and emphasizes the importance of critical analysis in advancing research in this field.